Significance of the expression of proliferation-associated nucleolar antigen p120 in human colorectal tumors

Human Pathology

Volumn 28, Issue 1, 1997, Pages 74-79

  Ueki, Takashi ^b   Nakayama, Yoshifumi ^b   Sugao, Yoriaki ^b   Kohno, Kimitoshi ^b   Matsuo, Kenichi ^b   Sugimoto, Yoshikazu ^b   Yamada, Yuuji ^b   Kuwano, Michihiko ^b   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

adenoma carcinoma sequence; colorectum; Ki 67; p120; proliferation association antigen

Indexed keywords

CYCLINE; MONOCLONAL ANTIBODY KI 67;

ADENOMATOUS POLYP; ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; COLON MUCOSA; COLORECTAL TUMOR; HISTOGENESIS; HUMAN; HUMAN TISSUE; NUCLEOLUS; PROTEIN EXPRESSION;

EID: 0031039181     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90282-3     Document Type: Article

References (40)

1. Busch H, Busch RK, Chan PK, et al: Nucleolar antigens in cancer tissues. J Tumor Marker Oncol 1:69-80, 1986
2. Helpap B: Nucleolar grading of breast cancer: Comparative studies on frequency and localization of nucleoli and histology, stage, hormonal receptor status and lectin histochemistry. Virchows Arch [A] 415:501-508, 1989
3. Helpap B, Knupffer J, Essmann S: Nucleolar grading of renal cancer: Correlation of frequency and localization of nucleoli to histologic and cytologic grading and stage of renal cell carcinomas. Mod Pathol 3:671-678, 1990
4. Shimazui T, Koiso K, Uchiyama Y: Morphometry of nucleoli as an indicator for grade of malignancy of bladder tumors. Virchows Arch [B] 59:179-183, 1990
5. Freeman JW, Busch RK, Ross BE, et al: Masking of nontumorous antigens for development of human tumor nucleolar antibodies with improved specificity. Cancer Res 45:5637-5642, 1985
6. Fonagy A, Swiderski C, Wilson A, et al: Cell cycle regulated expression of nucleolar antigen p120 in normal and transformed human fibroblasts. J Cell Physiol 154:16-27, 1993
7. Fonagy A, Swiderski C, Ostrovsky AM, et al: Effect of nucleolar p120 expression level on the proliferation capacity of breast cancer cells. Cancer Res 54:1859-1864, 1994
8. Freeman JW, Hazlewood JE, Bondada V, et al: Proliferation-related nucleolar antigens p145 and p120 associated with separate nucleolar elements and differences in tissue distribution. Cancer Commun 1:367-372, 1989
9. Freeman JW, McGrath P, Bondada V, et al: Prognostic significance of proliferation associated nucleolar antigen p120 in human breast carcinoma. Cancer Res 51:1973-1978, 1991
10. Freeman JW, Hazlewood JE, Auerbach P, et al: Optimal loading of scraped HeLa cells with monoclonal antibodies to the proliferation-associated Mr 120,000 nucleolar antigen. Cancer Res 48:5246-5250, 1988
11. Perlaky L, Saijo Y, Busch RK, et al: Growth inhibition of human tumor cell lines by antisense oligonucleotides designed to inhibit p120 expression. Anticancer Drug Des 8:3-14, 1993
12. Saijo Y, Perlaky L, Valdez BC, et al: The effect of antisense p120 construct on p120 expression and cell proliferation in human breast cancer MCF-7 cells. Cancer Lett 68:95-104, 1993
13. Morson BC, Dawson IMP: Gastrointestinal pathology. Oxford, London, Blackwell Scientific, 1990
14. Vogelstein B, Fearon ER, Hamilton SR, et al: Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532, 1988
15. Brown DC, Gatter KC: Monoclonal antibody Ki-67: Its use in histopathology. Histopathology 17:489-503, 1990
16. Busch H: The final common pathway of cancer: Presidential address. Cancer Res 50:4830-4838, 1990
17. Kohler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 265:495-497, 1975
18. Shi ZR, Itzkowitz SH, Kim YS: A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues. J Histochem Cytochem 36:317-322, 1988
19. Sahin AA, Ro JY, Brown RW, et al: Assessment of Ki-67-derived tumor proliferative activity in colorectal adenocarcinomas. Mod Pathol 7:17-22, 1994
20. Jass JR, Sobin LH: WHO histological typing of intestinal tumours. Berlin, Germany, Springer-Verlag, 1989
21. Hamanaka R, Kohno K, Swguchi T, et al: Induction of low density lipoprotein receptor and a transcription factor SP-1 by tumor necrosis factor in human microvascular endothelial cells. J Biol Chem 267:13160-13165, 1992
22. NakayamaY: Microtubule reorganization and lysosome redistribution by a viral v-src oncogene, in mouse balb/3T3 cells expressing human EGF receptor. Cell Struct Funct 19:397-409, 1994
23. Valdez BC, Busch RK, Larson RG, et al: Identification of an epitope region of the human proliferation-associated nucleolar antigen P120. Cancer Res 50:2704-2707, 1990
24. Perlaky L, Valdez BC, Busch RK, et al: Increased growth of NIH/3T3 cells by transfection with human p120 complementary DNA and inhibition by a p120 antisense construct. Cancer Res 52:428-436, 1992
25. Diebold J, Lai MD, Lohrs U: Analysis of proliferative activity in colorectal mucosa by immunohistochemical detection of proliferating cell nuclear antigen (PCNA). Methodological aspects and application to routine diagnostic material. Virchows Arch [B] 62:283-289, 1992
26. Maasken AP, Deschner EE: Triated thymidine incorporation into epithelial cells of normal appearing colorectal mucosa of cancer patients. J Natl Cancer Inst 58:1221-1224, 1977
27. Connelly JH, Bruner JM, Robey Cafferty SS, et al: p53 Protein expression in transitional mucosa and adenocarcinomas of the colorectum. Mod Pathol 5:537-539, 1992
28. Williams GT: Transitional mucosa of the large intestine. Histopathology 9:1237-1243, 1985
29. Jaskulski D, Gatti G, Travalli S, et al: Regulation of the proliferating cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors. J Biol Chem 263:10175-10179, 1988
30. Burgess A: Growth factors and oncogens. Immunol Today 6:107-112, 1985
31. Al-Sheneber IF, Shibata HR, Sampalis J, et al: Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer 71:1954-1959, 1993
32. Freeman JW, Busch H: Monoclonal antibodies to human tumor nucleolar antigens: Probes for studying biological function and determining clinical significance. Hum Antibodies Hybridomas 2:4-10, 1991
33. Mingazzini PL, Scucchi L, Di SD, et al: Expression of interphasic nucleolar organizer regions in normal, dysplastic and neoplastic colorectal mucosa. Virchows Arch [A] 419:487-491, 1991
34. Ochs RL, Reilly MT, Freeman JW, et al: Intranucleolar localization of human proliferating cell nucleolar antigen p120. Cancer Res 48:6523-6529, 1988
35. Morton CC, Brown JA, Holmes WM, et al: Stain intesnsity of human nucleolus organizer region reflects incorparation of uridine into mature ribosomaal RNA. Exp Cell Res 145:405-413, 1983
36. Ruschoff J, Bittinger A, Neumann K, et al: Prognostic significance of nucleolar organizing regions (NORs) in carcinomas of the sigmoid colon and rectum. Pathol Res Pract 186:85-91, 1990
37. Freeman JW, Busch RK, Gyorkey F, et al: Identification and characterization of a human proliferation-associated nucleolar antigen with a molecular weight of 120,000 expressed in early G1 phase. Cancer Res 48:1244-1251, 1988
38. Johnston PG, O'Brien MJ, Dervan PA, et al: Immunohistochemical analysis of cell kinetic parameters in colonic adenocarcinomas, adenomas, and normal mucosa. HUM PATHOL 20:696-700, 1989
39. Linden MD, Ma CK, Kubus J, et al: Ki-67 and proliferating cell nuclear antigen tumor proliferative indices in DNA diploid colorectal adenocarcinomas: Correlation with histopathologic characteristics and cell cycle analysis with two-color DNA flow cytometry. Am J Clin Pathol 100:206-212, 1993
40. Kubota Y, Petras RE, Easley KA, et al: Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. A multivariate analysis. Cancer 70:2602-2609, 1992